Tykerb

Tykerb is the brand name for a new anti-cancer drug called lapatinib. Tykerb is given in combination with capecitabine (another anti-cancer medicine) for the treatment of advanced or metastatic (meaning the cancer has spread to other parts of the body) breast cancer. It is used in tumours that express a specific protein called HER2 and which have already been treated with certain other breast cancer treatments (in particular an anthracycline, a taxane, and Herceptin). Please refer to our chemotherapy treatment article for further information on how chemotherapeutic agents work. Studies have shown that combined therapy with Tykerb and capecitabine is better than capecitabine alone, and is effective at preventing tumour progression.

• Tykerb

• Anzatax
• Femara
• Mitozantrone injection
• Nolvadex, nolvadex-d
• Postinor-2
• Taxotere
• Tykerb